Longwood Fund

General contacts
Investor type

VC

Founded

2010

AUM

$60 000 M

Location

Boston, Massachusetts, United States

Investment Ticket

$10-50 m

Investment Stage

Series A Seed Series B

Region of investment

North America Europe
Investor profile last updated: 12 August, 2026

Profile

Longwood Fund is a venture capital firm based in Boston, Massachusetts, known for creating and investing in science-driven companies addressing critical medical issues. The firm was co-founded by Christoph Westphal, who has a history of building and leading biotechnology firms. Longwood Fund operates with a team of seasoned professionals, often taking active roles in their portfolio companies, such as Co-Founding CEOs, CBOs, or Presidents.

The firm focuses on the healthcare sector, particularly in biotechnology and pharmaceuticals. Its investment strategy targets early-stage companies innovating in areas like novel therapeutics and medical technologies, primarily within North America. The firm does not publicly disclose its total assets under management.

Notable investments by Longwood Fund include Pyxis Oncology, Werewolf Therapeutics, TScan Therapeutics, and Pulmocide. These companies span innovative therapeutic development and biotechnologies. Additionally, Longwood Fund has been instrumental in co-founding significant ventures such as Immunitas Therapeutics and Be Biopharma.

Industry

HealthTech Biotechnology Healthcare Services Medical Devices Pharmaceuticals

Contacts

Name
Title
Email
Social Networks
avatar
Christoph Westphal Co-Founder & General Partner
Co-Founder & General Partner
c•••@•••
avatar
Aleks Radovic-Moreno Partner
Partner
a•••@•••
LinkedIn
Upgrade to see contacts
avatar
7QqI0ZwoKvJGaCnT 7QqI0ZwoKvJGaCnT
7QqI0ZwoKvJGaCnT
[email protected]
linkedin twitter
avatar
7QqI0ZwoKvJGaCnT 7QqI0ZwoKvJGaCnT
7QqI0ZwoKvJGaCnT
[email protected]
linkedin twitter
avatar
7QqI0ZwoKvJGaCnT 7QqI0ZwoKvJGaCnT
7QqI0ZwoKvJGaCnT
[email protected]
linkedin twitter
Investment-team contacts for Longwood Fund — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Longwood Fund

Longwood Fund is a venture capital firm. It backs companies at Series A, Seed and Series B, writing tickets of $10-50 m.
Longwood Fund is located in Boston, Massachusetts, United States.
Longwood Fund was founded in 2010.
Longwood Fund invests in companies and startups in HealthTech, Biotechnology, Healthcare Services, Medical Devices, Pharmaceuticals.
Longwood Fund invests in companies and startups in North America, Europe.
Longwood Fund invests in companies and startups at Series A, Seed, Series B.
Longwood Fund usually invests $10-50 m on average.
Longwood Fund has around $60 000m assets under management.
Longwood Fund can be reached through its website longwoodfund.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Longwood Fund — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Longwood Fund directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 12 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.